[EN] Lung cancer is a malignant disease with high mortality and poor prognosis, frequently diagnosed at advanced stages. Nowadays, immense progress in treatment has been achieved. However, the present scenario continues ...
Moreno Manuel, Andrea(Universitat Politècnica de València, 2019-05-08)
[ES] El cáncer de pulmón es la principal causa de muerte debida a cáncer a nivel mundial, siendo el cáncer de pulmón no microcítico (CPNM) el principal subtipo histológico, ya que representa el 80% de los casos de cáncer ...
[EN] Despite the success of immunotherapies in lung cancer, development of new biomarkers for patient selection is urgently needed. This study aims to explore minimally invasive approaches to characterize circulating T ...
Moreno Manuel, Andrea(Universitat Politècnica de València, 2017-09-05)
[EN] Lung cancer is the leading cause of cancer-related death worldwide, with a 5-year survival lower than
5% in advanced stages of the disease. Non-Small Cell Lung Cancer (NSCLC) represents approximately
80% of lung ...
Moreno Manuel, Andrea(Universitat Politècnica de València, 2025-04-22)
[ES] El cáncer de pulmón no microcítico (CPNM) representa un 80% de los casos de cáncer de pulmón, siendo uno de los tipos de cáncer más frecuentes y mortales. El tratamiento con inmunoterapia ha mejorado significativamente ...